Synthesis and characterization of 123I-CMICE-013: A potential SPECT myocardial perfusion imaging agent
Autor: | Yin Duan, Xuxu Yan, Yong-Xiang Chen, Terrence D. Ruddy, Corinne Bensimon, Lihui Wei, Julia Lockwood, J. Russell Redshaw, Peter A. Covitz, R. Glenn Wells, Pasan Fernando |
---|---|
Rok vydání: | 2013 |
Předmět: |
Male
Biodistribution Clinical Biochemistry Myocardial Infarction Pharmaceutical Science Single-photon emission computed tomography Heterocyclic Compounds 4 or More Rings Sensitivity and Specificity Biochemistry Iodine Radioisotopes Rats Sprague-Dawley Coronary artery disease Myocardial perfusion imaging Left coronary artery Pharmacokinetics In vivo Rotenone medicine.artery Drug Discovery medicine Animals Humans Tissue Distribution Molecular Biology Tomography Emission-Computed Single-Photon medicine.diagnostic_test business.industry Chemistry Organic Chemistry Myocardial Perfusion Imaging Heart medicine.disease Rats Chromones Reperfusion Injury Molecular Medicine Radiopharmaceuticals Nuclear medicine business Perfusion |
Zdroj: | Bioorganic & Medicinal Chemistry. 21:2903-2911 |
ISSN: | 0968-0896 |
DOI: | 10.1016/j.bmc.2013.03.080 |
Popis: | Coronary artery disease (CAD) is a major cause of death in Canada and the United States. Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is a useful diagnostic test in the management of patients with CAD. The widely used SPECT MPI agents, 99m Tc sestamibi and 99m Tc tetrofosmin, exhibit less than ideal pharmacokinetic properties with decreasing uptake with higher flows. 123 I has a similar energy as 99m Tc, an ideal half life, and is readily available from cyclotrons. The objective of this study was to develop an 123 I labeled MPI agent based on rotenone, a mitochondrial complex I inhibitor, as an alternative to currently available SPECT MPI agents. Methods : 123 I-CMICE-013 was synthesized by radiolabeling rotenone with 123 I in trifluoroacetic acid (TFA) with iodogen as the oxidizing agent at 60 °C for 45 min, followed by RP-HPLC purification. The product was formulated in 5% EtOH in 10 mM NaOAc pH 6.5. The inactive analog 127 I-CMICE-013 was isolated and characterized by NMR and mass spectrometry, and the structure determined. Micro-SPECT imaging studies were carried out in normal and infarcted rats. Biodistribution studies were performed in normal rats at 2 h ( n = 6) and 24 h ( n = 8) post injection (p.i.). Results : 123 I-CMICE-013 was isolated with >95% radiochemical purity and high specific activity (14.8–111 GBq/μmol; 400–3000 mCi/μmol). Structural analysis showed that rotenone was iodinated at 7′-position, with removal of the 6′,7′-double bond, and addition of a hydroxy group at 6′-position. MicroSPECT images in normal rats demonstrated homogeneous and sustained myocardial uptake with minimal interference from lung and liver. Absent myocardial perfusion was clearly identified in rats with permanent left coronary artery ligation and ischemia-reperfusion injury. In vivo biodistribution studies in normal rats at 2 h p.i. showed significant myocardial uptake (2.01 ± 0.48%ID/g) and high heart to liver (2.98 ± 0.93), heart to lung (4.11 ± 1.04) and heart to blood (8.37 ± 3.97) ratios. At 24 h p.i., the majority of 123 I-CMICE-013 was cleared from tissues, and a significant amount of tracer was found in the thyroid, indicating in vivo deiodination of the tracer. Conclusion : 123 I-CMICE-013 is a promising new radiotracer for SPECT MPI with high myocardial uptake, very good target to background ratios and favorable biodistribution characteristics. |
Databáze: | OpenAIRE |
Externí odkaz: |